3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
18
Glioma
11
Neoplasms
6
Brain Neoplasms
6
Astrocytoma
6
Neuroblastoma
4
Sarcoma, Ewing
3
Gliosarcoma
3
Sarcoma
2
Rhabdomyosarcoma
2
Recurrence
2
Pancreatic Neoplasms
2
Medulloblastoma
2
Diffuse Intrinsic Pontine Glioma
2
Wilms Tumor
1
Spinal Cord Neoplasms
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm Metastasis
1
Melanoma, Cutaneous Malignant
1
Melanoma
1
Lymphoma, Follicular
1
Hepatoblastoma
1
Ganglioneuroblastoma
1
Interventions
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Methotrexate
3
Cytarabine
3
venetoclax
2
ponatinib
2
merphos
2
fludarabine phosphate
2
Tacrolimus
2
Idarubicin
2
Etoposide
2
Cyclosporine
2
Cyclophosphamide
2
Cladribine
2
Busulfan
2
midostaurin
1
gilteritinib
1
blinatumomab
1
Thiotepa
1
Sirolimus
1
Razoxane
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Melphalan
1
Injections
1
Gemtuzumab
1
Dexrazoxane
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Blast Crisis
×
Temozolomide
×
30 days
×
Clear all
No trials found.